Antony goes global to present his researchCLAHRC NWC PhD Student Antony Martin presented his research at the 23rd Annual Meeting, International Society for Pharmacoeconomics and Outcomes Research (ISPOR) conference, in Baltimore, earlier this year and has now been asked to deliver it on the other side of the globe.
In addition to Antony discussing his research with leading health economists and operational researchers in the USA, he has now been chosen to participate in a Newton Funded three day training workshop on ‘Economic analysis of large medical databases’ at Peking University in Beijing, China. The workshop provides an opportunity to share research ideas and collaborate with leading researchers from the UK and China. He also hopes to catch-up with his old university classmates from his exchange semester in China (attached picture taken almost 10 years ago!).
The study objective of his research is to investigate whether all eligible patients with HER2+ breast cancer initiated trastuzumab therapy. A systematic review of observational studies was conducted and data were synthesized with meta-analysis. Uptake of trastuzumab varied widely between studies and across subgroups and this research highlighted the need for improved access to disaggregated data which may permit a deeper understanding into health inequalities.
Trastuzumab uptake in HER2-positive breast cancer patients: a systematic review and meta-analysis of observational studies has provisionally been accepted for publications and work already published by Antony includes:
Martin A, Downing J, Maden M, Fleeman N, Alfirevic A, Haycox A, Pirmohamed M: An assessment of the impact of pharmacogenomics on health disparities: a systematic literature review, Pharmacogenomics 2 Nov 2017 https://doi.org/10.2217/pgs-2017-0076
More articles Posted on: 20 August 2018